CPC A23L 33/105 (2016.08) [A23L 2/52 (2013.01); A61K 9/0095 (2013.01); A61K 31/05 (2013.01); A61K 31/122 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 31/352 (2013.01); A61K 31/4045 (2013.01); A61K 31/4415 (2013.01); A61K 31/7004 (2013.01); A61K 31/7016 (2013.01); A61K 33/06 (2013.01)] | 18 Claims |
1. A dietary composition formulated in a therapeutic effective amount to promote restful sleep in humans or animals consisting of a blend of:
a first substance selected from the group consisting of humulone, xanthohumol, myrcenol, and combinations thereof;
a second substance selected from the group consisting of honokiol, magnolol, and combinations thereof;
a third substance selected from the group consisting of rosavine, tyrosol, salidroside, and combinations thereof;
a fourth substance selected from the group consisting of rosmarinic acid, epigallocatechin gallate, and combinations thereof;
melatonin;
L-theanine;
magnesium;
vitamin B6 and
optionally an excipient;
wherein the dietary composition is in the form of a pill, a capsule, a tablet, a softgel, a lozenge, a powder, a liquid, a food, a beverage, a gummy, or an orally-dissolving film strip.
|